The immunology of corneal graft rejection

Critical Reviews in Immunology

Volumn 18, Issue 4, 1998, Pages 305-325

  Rocha, Guillermo ^a,b,d   Deschênes, Jean ^b   Rowsey, J James ^c  

^a SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d FRCSC   (United States)

Author keywords

ACAID; Corneal graft rejection; Corneal transplantation; Immune tolerance; Immunosuppression; Ocular immune privilege

Indexed keywords

15 DEOXYSPERGUALIN; ALPHA INTERMEDIN; AMINOGUANIDINE; CALCITONIN GENE RELATED PEPTIDE; CYCLOSPORIN A; CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; MISOPROSTOL; N(G) METHYLARGININE; NITRIC OXIDE; RAPAMYCIN; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ANTIGEN PRESENTING CELL; AQUEOUS HUMOR; BLOOD EYE BARRIER; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031927760     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v18.i4.20     Document Type: Review

References (167)

1. Streilein, J. W., Unraveling immune privilege, Nature, 270, 1158-1159, 1995.
2. The Collaborative Corneal Transplantation Studies Research Group; The Collaborative Corneal Transplantation Studies (CCTS), Arch. Ophtalmol., 110, 1392-1403, 1992.
3. Coster, D. J. and Williams, K. A., Transplantation of the cornea, Med. J. Austr., 157(6), 405-408, 1992.
4. Lomholt, J. A., Baggesen, K., and Ehlers, N., Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis, Acta Ophthalmol. Scand., 73(1), 29-32, 1995.
5. Joo, C. K., Pepose, J. S., and Stuart, P. M., T-cell mediated responses in a murine model of orthotopic corneal transplantation, Invest. Ophthalmol. Vis. Sci., 36, 1530-1540, 1995.
6. Polack, F. M., Editorial, on recent advances-corneal transplantation, Invest. Ophthalmol, 12, 85-86, 1973.
7. Wood, T. O. and Tuberville, A. W., Results of surgery, in Corneal Surgery, Theory, Technique and Tissue, 2nd ed., Brightbill, F. S., Ed., Mosby-Year Book, St. Louis, MO, 1993, 118-124.
8. Wilson, S. E. and Kaufman, H. F., Graft failure after penetrating keratoplasty, Surv. Ophthalmol., 34, 325- 356, 1990.
9. Caprioli, J., Chapter 7: The ciliary epithelia and aqueous humor, in Adler's Physiology of the Eye, 9th ed., Hart, W. M., Jr., Ed., Mosby-Year Book, St. Louis, MO, 1992, 228-247.
10. Rocha, G. and Deschênes, J., Pathophysiology and treatment of cysiod macular edema, Can. J. Ophthalmol., 31(6), 282-288, 1996.
11. Robin, J.B., Schanzilin, D.J., Verity, S.M., et.al., Peripherial corneal disorders, Surv. Ophthalmol., 31, 1-31, 1996.
12. Niderkorn, J.Y., Ross, J.R., and He, Y., Effect of donor Langehans cells on corneal graft rejection, J. Invest. Dermatol., 99(5), 104S-106S, 1992.
13. Beebe, D.C., and Masters, G., Dong, G., et al., Chapter 5: Limbal location of corneal-epithelial cells, in The Cornea: Transactions of the World Congress on the Cornea III, Cavanagh, H. D., Ed., Raven Press, New York, NY, 1988, 23-25.
14. Beebe, D. C. and Masters, B. R., Cell lineage and the differentiation of corneal epithelial cells, Invest. Ophthalmol. Vis. Sci., 37, 1815-1825, 1996,
15. Tsai, R. J. F. and Tseng, S. C. G., Effect of stromal inflammation on the outcome of limbal transplants tion for corneal surface reconstruction, Cornea, 14(5), 439-449, 1995.
16. Kim, J. C. and Tseng, S. C. G., Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas, Cornea, 14(5), 473-484, 1995.
17. Wiley, L., Sundar Raj, N., Sun, T. T., and Thoft, R. A., Regional heterogeneity in human corneal and limbal epithelia: an immunohistochemical evaluation, Invest. Ophthalmol. Vis. Sci., 32(3), 594-602, 1991.
18. Aral, K., Lee, F., Miyajima, A., Miyatake, S., Aral, N., and Yokota, T., Cytokines: coordinators of immune and inflammatory responses, Annu. Rev. Biochem., 59, 783-836, 1990.
19. Mossman, T. R. and Coffman, R. L., Heterogeneity of cytokine secretion patterns and functions of helper T cells, Adv. Immunol., 46, 111-147, 1989.
20. Li, D. and Tseng, S. C. G., Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surfacee J. Cell. Physiol., 163, 61-79, 1995,
21. 20a. Weng, J., Mohan, R. R., Li, Q., and Wilson, S. E., IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-lbeta expression in the cornea, Cornea, 16(4), 465-471, 1997.
22. Mizuki, N., Inoko, H., and Ohno, S., Role of HLA and T lymphocytes in the immune responses, Ocular Immunol. Inflamm., 2(2), 57-91, 1994.
23. +/T6 Langerhans cells of the human cornea, Invest, Ophthalmol. Vis. Sci., 28(10), 1719-1722, 1987.
24. Streilein, J. W., Toews, G. B., and Bergstresser, P. R., Corneal allografts fail to express Ia antigens, Nature, 282, 326-327, 1979.
25. McMenamin, P. G. and Holthouse, I., Immunohistochemical characterization of dendritic cells and macrophages in the aqueous outflow pathways of the rat eye, Exp. Eye Res., 55, 315-324, 1992.
26. McMenamin, P. G., Holthouse, L, and Holt, P. G., Class II major histocompatibility complex (Ia) antigen-bearing dendritic cells within the iris and ciliary body of the rat eye: distribution, phenotype, and relation to retinal microglia, J. Immunol., 77, 385-393, 1992.
27. Benson, J. L. and Niederkorn, J. Y., Interleukin-1 abrogates anterior chamber-associated immune deviation, Invest. Ophthalmol. Vis. Sci., 31, 2123-2128, 1990.
28. Choudhury, A., Pakalnis, V. A., and Bowers, W. E., Function and cell surface phenotype of dendritic cells from rat cornea, Invest. Ophthalmol. Vis. Sci., 36, 2602-2613, 1995.
29. Whitsett, C. F. and Stulting, R. D., The distribution of HLA-antigens on human corneal tissue, Invest. Ophthalmol. Vis. Sci., 25, 519-524, 1984.
30. Treseler, P. A., Foulks, G. N., and Sanfilippo, F., The expression of HLA-antigens by cells in the human cornea, Am. J. Ophthalmol., 98, 763-772, 1984.
31. Lynch, M. G., Peeler, J. S, , Brown, R. H., and Niederkorn, J. Y., Expression of HLA Class I and II antigens on cells of the human trabecular meshwork, Ophthalmology, 94, 851-857, 1987.
32. Bakker, M., Grumet, F. C., Feltkamp, T. E. W., and Kiylstra, A., HLA-antigens in the human uvea, Doc. Ophthalmol., 61, 271-279, 1986.
33. Wang, H. M., Kaplan, H. J., Chan, W. C., and Johnson, M., The distribution and ontogeny of MHCantigens in murine ocular tissue, Invest. Ophthalmol. Vis. Sci., 28, 1383-1389, 1987.
34. Granstein, R. D., Staszewski, R., Knisely, T. L., et al., Aqueous humor contains transforming growth factor-β and a small (< 3500 daltons) inhibitor of thymocyte proliferation, J. Immunol., 144(8), 3021-3027, 1990.
35. Eilingsworth, L. R., Nakayama, D., Segarlni, P., et al., Transforming growth factor-βs are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation, Cell. Immunol., 114, 41-54, 1988.
36. Massagué, J., The TGF-β family of growth and differentiation factors, Cell, 49, 437-438, 1987.
37. Sporn, M. B., Roberts, A. B., Wakefield, L. M., and Assoian, R. K., Transforming growth factor-β: biological function and chemical structure, Science, 233, 532-535, 1986.
38. Nishida, K., Sotozono, C., Adachi, W., et al., Transforming growth factor-βl, -β2, and -β3 mRNA expression in human cornea, Curr. Eye Res., 14, 235-241, 1995.
39. Pasquale, L. R., Dorman-Pease, M. E., Lutty, G. A., Quigley, H. A., and Jampel, H. D., Immunolocalization. of TGF-βl, TGF-β2, and TGF-β3 in the anterior segment of the human eye, Invest. Ophthalmol. Vis. Sci., 34, 23-30, 1993.
40. Kondo, K., Coca-Prados, M., and Sears, M., Human ciliary epithelia in moriolayer culture, Exp. Eye Res., 38, 423-433.
41. Runyan, T. E., McCombs, W, B., Holten, O. D., McCoy, C. E., and Morgan, M. P., Human ciliary body epithelium in culture, Invest. Ophthalmol. Vis. Sci., 24, 687-696, 1983.
42. Streilein, J. W. and Bradley, D., Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products, Invest. Ophthalmol. Vis. Sci., 32, 2700-2710, 1991.
43. Creyghton, W. M., Völker-Dieben, H. J., and Jager, M. J., Transforming growth factor-β2 levels in aqueous humor during corneal transplantation and cataract surgery, Ocular Immunol. Inflamm., 3(1), 29-36, 1995.
44. Streilein, J. W., Immunological nonresponsiveness and acquisition of tolerance in relation to immune privilege in the eye, Eye, 9, 236-240, 1995.
45. 1 lymphocyte-induced immune deviation, J. Immunol., 118(3), 809-814, 1977.
46. 1 lymphocyte-induced immune deviation, J. Immunol., 120(3), 689-693, 1978.
47. Streilein, J. W., Anterior chamber associated immune deviation: the privilege of immunity in the eye, Surv. Ophthalmol., 35(1), 67-73, 1990.
48. Niederkorn, J. Y. and Streilein, J. W., Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed type hypersensitivity but normal cytotoxic T lymphocyte responses, J. Immunol., 131, 2670-2674, 1983.
49. Niederkorn, J. Y., Streilein, J. W., and Kripke, M. L., Promotion of syngeneic intraocular tumor growth in mice by anterior chamber-associated immune deviation, JNCI, 71, 193-200, 1983.
50. Sano, Y., Ksander, B. R., and Streilein, J. W., Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction, Invest. Ophthalmol, Vis. Sci., 36, 2176-2185, 1995.
51. Sonoda, Y. and Streilein, J. W., Impaired cell mediated immunity in mice bearing healthy orthotopic corneal allografts, J. Immunol., 150, 1727-1734, 1993.
52. Streilein, J. W., Immune regulation and the eye: a dangerous compromise, FASEB J., 1, 199-208, 1987.
53. Streilein, J. W., Ocular immune privilege and the Faustian dilemma. The Proctor Lecture, Invest. Ophthalmol. Vis. Sci-, 37(1), 1940-1950, 1996.
54. Streilein, J. W. and Cousins, S. W., Aqueous humor factors and their effect on the immune response in the anterior chamber, Curr. Eye Res., 9(Suppl), 175-182, 1990.
55. Streilein, J. W., Cousins, S., and Bradley, D., Effect of intraocular gamma-Interferon on immunoregulatory properties of iris and ciliary body cells, Invest. Ophthalmol. Vis. Sei., 33, 2304-2315, 1992.
56. Streilein, J. W. and Kaiser, C. J., Immunosuppressive properties of aqueous humor as it relates to uveitis, in Proceedings from the First World Uveitis Symposium, Belfort, Jr., R., Petrilli, A, M, N., and Nussenblatt, R., Eds., Livraria Roca Ltda., Sap Paulo, 1989, 3-13.
57. Streilein, J. W., Niederkorn, J. Y., and Shadduck, J. A., Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocpmpatibility antigens, J. Exp. Med., 152, 1121-1125, 1980,
58. Streilein, J. W. and Niederkorn, J. Y., Induction of anterior chamber-associated immune deviation requires an intact, functional spleen, J. Exp. Med., 153, 1058-1067, 1981.
59. Streilein, J. W. and Sonoda, Y., Anterior chamber privilege in relation to keratoplasty, in Immunology of Corneal Transplantation Zierhut, M., Pleyer, U., and Thiel, H. U., Eds., Butterworth Heinemann, Boston, MA, 1994, 117-134.
60. Waldrep, J. C. and Kaplan, H. J., Anterior chamber associated immune deviation induced by TNPsplenocytes (TNP-ACAID). I. Systemic tolerance mediated by suppressor cells, Invest. Ophthalmol. Vis. Sci., 24, 1086-1092, 1983.
61. Mizuno, K., Clark, A. F., and Streilein, J. W., Anterior chamber-associated immune deviation induced by soluble antigens, Invest. Ophthalmol. Vis. Sci., 30(6), 1112-1119, 1989.
62. Sonoda, Y. and Streilein, J. W., Orthotopic corneal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply, Transplantation, 54(4), 694-704, 1992.
63. Benson, J. L. and Niederkorn, J. Y., The presence of donor-derived class II-positive cells abolishes immune privilege in the anterior chamber of the eye, Transplantation, 51(4), 834-838, 1991.
64. Whittum, J. A., Niederkorn, J. Y., McCulley, J. P., and Streilein, J. W., Intracameral inoculation of herpes simplex virus type I induces anterior chamber associated immune deviation, Curr. Eye Res., 2, 691-697, 1983.
65. Rao, N. A., Robin, J., Hartmann, D., Sweeney, J. A., and Marak, Jr., G. E., The role of the penetrating wound in the development of sympathetic ophthalmia, Arch. Ophthalmol., 101(1), 102-104, 1983.
66. Wilbanks, G. A. and Streilein, J. W., Suppression of delayed hypersensitivity in vivo by an ACAID-inducing signal created in vitro, Invest. Ophthalmol. Vis. Sci., 33(4), 1283, 1992.
67. Ferguson, T. A. and Herndon, J. M., The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen, Invest. Ophthalmol. Vis. Sci., 35, 3085-3093, 1994.
68. Wilbanks, G. A., Mammolenti, M., and Streilein, J. W., Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eyederived cells participate in generating blood-born signals that induce ACAID, J.Immunol., 146, 3018-3024, 1991.
69. Hughes, C. C. and Pober, J. S., Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased c-fos content of AP-1, J. Immunol., 150, 3148-3160, 1993.
70. Wilson, S, E., Li, Q., Weng, J., et al., The Fas-Fas ligand system and other modulators of apoptosis in the cornea, Invest. Ophthalmol. Vis. Sci., 37, .1582-1592, 1996.
71. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., and Ferguson, T. A., Fas iigand-induced apoptosis as a mechanism of immune privilege, Science, 270(5239), 1189-1192, 1995.
72. Zheng, L., Fisher, G., Miller, R. E., et al., Induction of apoptosis in mature T cells by tumor necrosis factor, Nature, 377, 348-351, 1995.
73. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., and Duke, R. C., A role for CD95 ligand in preventing corneal graft rejection, Nature, 377, 630-632, 1995.
74. Bhattacherjee, P., The role of Arachidonate Metabolites in Ocular Inflammation, Alan R. Liss, St. Louis, MO, 1989, 211-227.
75. Sullivan, W. R., Routine postoperative management, in Corneal Surgery, Theory, Technique and Tissue, 2nd ed., Brightbill, F. S., Ed., Mosby-Year Book, St. Louis, MO, 1993, 225-227.
76. Rulo, A. H., Greve, E. L., Geijssen, H. C., and Hoyng, P. F. J., Reduction of intraocular pressure with treatment of lantanoprost once daily in patients with normal-pressure glaucoma, Ophthalmology, 103, 1276-1282, 1996.
77. Kaminska, G. M. and Niederkorn, J. Y., Spontaneous corneal neovascularization in nude mice. Local imbalance between angiogenic and antiangiogenic factors, Invest. Ophthalmol Vis. Sci., 34, 222-230, 1993.
78. Epstein, R. J., Hendricks, R. L., and Stulting, R. D., Interleukin-2 induces corneal neovascularization in A/J mice, Cornea, 9(4), 318-323, 1990.
79. Apel, A., Oh, C., Chiu Saville, B., Cheng, Y. L., and Rootman, D., A subconjunctival degradable implant for cyclosporine delivery in corneal transplant therapy, Curr. Eye Res., 14, 659-667, 1995.
80. Kelley, J. G., Ohashi, Y., and Friedlaender, M. H., Langerhans cell alterations in the guinea pig cornea, Invest. Ophthalmol Vis. Sci., 26, 1293-1296, 1985.
81. Collin, H. B., Corneal lymphatics in alloxan vascularized rabbit eyes, Invest. Ophthalmol. Vis. Sci., 5(1), 1-13, 1966.
82. Williamson, J. S. P., DiMarco, S., and Streilein, J. W., Immunobiology of Langerhans cells on the ocular surface, Invest. Ophthalmol. Vis. Sci., 28, 1527-1532, 1987.
83. Philipp, W. and Göttinger, W., T6-positive Langerhans cells in diseased corneas, Invest. Ophthalmol. Vis. Sci., 32, 2492-2497, 1991.
84. Philipp, W. and Göttinger, W., Leukocyte adhesion molecules in diseased corneas, Invest. Ophthalmol. Vis. Sci., 34, 2449-2459, 1993.
85. Unanue, E. R. and Cerottlnl, J. C., Antigen presentation, FASEB J., 3, 2496-2502, 1989.
86. Allison, J. P. and Krummel, M. F., The Yin and Yang of T cell costimulation, Science, 270(10), 932-933, 1995.
87. Iwata, M., Yagihashi, A., Roat, M. I., et al., Human leukocyte antigen Class II positive human corneal epithelial, cells activate allogenic T cells, Invest. Ophthalmol. Vis. Sci., 35, 3991-4000, 1994.
88. Mossman, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, J. Immunol., 136(7), 2348-2357, 1986.
89. Suthanthiran, M. and Strom, T. B., Renal transplantation, N. Engl, J. Med., 331(6), 365-376, 1994.
90. Fink, N., Stulting, R. D., Maguire, M. G., et al., Effectiveness of histocompatibility matching in highrisk corneal transplantation: a summary of results from the collaborative corneal transplantation studies, in Immunology of Corneal Transplantation, Zierhut, M., Pleyer, U., and Thiel, H. U., Eds., Butterworth Heinemann, Boston, MA, 1994, 163-175.
91. The Collaborative Corneal Transplantation Studies Research Group: Design and methods of the Collaborative Corneal Transplantation Studies, Cornea, 12(2), 93-103, 1993.
92. 90a. Roy, R., Des Marchais, B., Bazin, R., Boisjoly, H. M., Dubé, L, and Laughrea, P. A., Role of ABO and Lewis blood group antigens in donor-recipient compatibility of corneal transplantation rejection, Ophthalmology, 104, 508-512, 1997.
93. Goulmy, E., Pool, J., Lochem, E. V., and VölkerDieben, H., The role of human minor histocompatibility antigens in graft failure: a mini-review, Eye, 9, 180-184, 1995.
94. Goulmy, E., Schipper, R., Pool, J., et al., Mismatches of minor histocompatibility antigens between HLAidentical donors and recipients and the development of graft-vs.-host disease after bone marrow transplantation, N. Engl J. Med., 334(5), 281-285, 1996.
95. 92a. Sano, Y., Ksander, B. R., and Streilein, J. W., Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens, Invest. Ophthalmol. Vis. Sci., 38, 1130-1138, 1997.
96. Guymer, R. H. and Mandel, T. E., A comparison of corneal, pancreas, and skin grafts in mice. A study of the determinants of tissue immunogenicity, Transplantation, 57(8), 1251-1262, 1994.
97. Roelen, D. L., van Beelen, E., van Bree, S.P., et al. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts, Transplantation, 59(7), 1039-1042, 1995.
98. Nicholls, S. M., Bradley, B. A., and Easty, D. L., Non-MHC antigens and their relative resistance to immunosuppressoin after corneal tranplantation, Eye, 9, 208-214, 1995.
99. El-Asrar, A. M. A., Van den Oord, J. J., Billiau, A., et al. Recombinant interferon-garnma induces HLA-expression on human corneal epithelial and endothelial cells in vitro; a preliminary report, Br. J. Ophthalmol., 73, 587, 1989.
100. Young, E., Stark, W. J., and Prendergast, R. A., Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells, Invest. Ophthalmol. Vis. Sci., 26, 571-574, 1985.
101. Asubel, F. M., Current Protocols in Molecular Biology, Greene Publishing Associates and WileyInterscience, New York, 1989.
102. Yamamoto, Y., Okubo, S., Klein, T. W., et al., Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA, Infect. Immun., 62(9), 3947-3956, 1994.
103. Alberts, B., Bray, D., Lewis, J., et al., Molecular Biology of the Cell, 3rd ed., Garland Publishing, New York, NY, 1994, 316-318.
104. Planck, S. R., Huang, X. N., Robertson, J. E., and Rosenbaum, J. T., Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment, Invest. Ophthalmol. Vis, Sci., 35, 924-930, 1994.
105. Power, W. J., Kaufman, A. H., Merayo-Lloves, J., Arrunategui-Correa, V., and Foster, C. S., Expression of collagens I, III, IV, and V mRNA in excimer wounded rat cornea: analysis by semiquantitative PCR, Curr. Eye Res., 14, 879-886, 1995.
106. 102a. Torres, P. F., de Vos, A. F., van der Gaag, R., Martins, B., and Kijlstra, A., Cytokine mRNA expression during experimental corneal allograft rejection, Exp. Eye Res. 63, 453-461, 1996.
107. Chalifour, L. E., Fahmy, R., Holder, E. L., et al., A method for analysis of gene expression patterns, Annal. Biochem., 216, 299-304, 1994.
108. 103a. Rocha, G., Sánchez-Thorin, J. C., Yamamoto, Y., et al., mRNA analysis in rat cornea, and iris/ciliary body in normal, prevascularized, and previously grafted eyes, Invest. Ophthalmol Vis. Sci., 37(3), S866 (abstract), 1996.
109. Rocha, G., Duclos, A., Chalifour, L. E., et al., Analysis of gene expression during experimental uveitis in the rabbit, Can. J. Ophthalmol., 31(5), 228-233, 1996.
110. Liang, P. and Pardee, A. B., Differential display of eukaryotic messenger RNA by means of the polyrherase chain reaction, Science, 257(14), 967-971, 1992.
111. Van Groningen, J. J. M., Bloemers, H. P. J., and Swart, G. W. M., Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display, Cancer Res., 55, 6237-:6243, 1995.
112. Duijvestijn, A. M., Cytokines and cell adhesion molecules in transplantation, in Immunology of Corneal Transplantation, Zierhut, M., Pleyer, U., and Thiel, H.U., Eds., Buttetworth Heinemann, Boston, MA, 1994, 27-40.
113. Ferguson, T. A., Herndon, J. M., and Dube, P., The immune response and the eye: a role for TNF-alpha in anterior chamber-associated immune deviation, Invest. Ophthalmol Vis. Sci., 35, 2641-2651, 1994.
114. 108a. Cubitt; C. L., Lausch, R. N., and Oakes, J. E., Differential induction of GRO-alpha gene expression in human corneal epithelial cells and keratocytes exposed to proinflammatory cytokines, Invest. Ophthalmol Vis, Sci., 38, 1149-1158, 1997.
115. Yaza, B. K., Brooks, J. H., and Mizel, S. B., Induction of AP-1 transcription factor component during T cell activation by IL-1 and phorbol ester, Cell Growth Differentiation, 3(10) , 677-684, 1992.
116. Gazzinelli, R. T., Oswald, I. P., Hieny, S., James, S. L., and Sher, A., The microbicidal activity of interferon-garnma-treated macrophages against Tripanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β, Eur. J. Immunol., 22, 2501-2506, 1992.
117. Rocha, G., Baines, M. G., Deschênes, J., et al., Transforming growth factor-β and nitric oxide levels during experimental uveitis, Can. J. Ophthalmol., 32(1), 17-24, 1997.
118. Vodovotz, Y., Bogdan, C., Palk, J., Xie, Q., and Nathan, C., Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β, J. Exp. Med., 178, 605-613, 1993.
119. de Boer, J. H., Limpens, J., Orengo-Nania, S., de Jong, P. T. V. M., La Heij, A., and Kijlstra, A., Low mature TGF-β2 levels in aqueous humor during uveitis, Invest. Ophthalmol. Vis. Sci., 35, 3702-3710, 1994.
120. Rocha, G., Baines, M. G., and Deschênes, J., The immunology of the eye and its systemic interactions, Crit. Rev. Immunol., 12(3, 4), 81-100, 1992.
121. Jager, M. J., Gregerson, D. S., and Streilein, J. W., Regulators of immunological responses in the cornea and the anterior chamber of the eye, Eye, 9, 241-246, 1995.
122. Jager, M. J., Kok, F. G., Broersma, L., and van der Gaaq, R., Changes in the immune response against BCP 54 following corneal transplantation in man, Transplantation, 55(6), 1379-1382, 1993.
123. Wackenheim-Urlacher, A., Kantelip, B., Falkenrodt, A., et al., T cell repertoire of normal, rejected, and pathological corneas: phenotype and function, Cornea, 14(5), 450-456, 1995.
124. Holland, E. J., Chan, C. C., Wetzig, R. P., Palestine, A. G., and Nussenblatt, R. B., Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model, Cornea, 10(5), 374-380, 1991.
125. Holland, E. J., Olsen, T. W. Chan, C. C., et al., Kinetics of corneal transplant rejection in the rat penetrating keratoplasty model, Cornea, 13(4), 317-323, 1994.
126. Zierhut, M. and Pleyer, U., Immunology of corneal graft rejection, in Immunology of Corneal Transplantation, Zierhut, M., Pleyer, U., and Thiel, H. U., Eds., Butterworth Heinemann, Boston, MA, 1994, 145-161.
127. Snyder, S. H. and Bredt, D. S., Biological roles of nitric oxide, Scienti. Am., 68-77, 1992.
128. Jaquemin, E., de Kozak, Y., Thillaye, B., Courtois, Y., and Goureau, O., Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats, Invest. Ophthalmol. Vis. Sci., 37(6), 1187-1196, 1996.
129. 122a. van der Veen, G., Broersma, L;, Briiyne, I., Verhagen, C., Ruijter, J., van Rij, G., and van der Gaag, R., Influx of immunoglobulins from the vascular compartment into a grafted cornea, Invest. Ophthalmol. Vis. Sci., 38, 876-883, 1997.
130. Hill, J. C., Immunosuppression in corneal transplantation, Eye, 9, 247-253, 1995.
131. Holland, E. J. and Olsen, T. W., Immunosupression in high-risk corneal transplantation, in Corneal surgery; Theory, Technique and Tissue, 2nd ed., Brightbill, F. S., Ed., Mosby-Year Book, St. Louis, MO, 1993, 260-268.
132. Kupiec-Weglinski, J. W. and Strom, T. B., Novel immunosupressive approaches in organ transplantation, in Immunology of Corneal Transplantation, Zierhut, M., Pleyer, U., and Thiel, H. U., Eds., Buttenvorth Heinemann, Boston, MA, 1994, 213-231.
133. Boisjoly, H., Tourigny, R., Bazin, R., et al., Risk factors of corneal graft failure, Ophthalmology, 100, 1728-1735, 1993.
134. He, Y. G. and Niederkorn, J. Y., Depletion of donor-derived Langerhans cells promotes corneal allograft survival, Cornea, 15(1), 82-89, 1996.
135. Billingham, R. E., The passenger cell concept in transplantation immunology, Cell. Immunol., 2, 1-12, 1971.
136. Armitage, W. J., The effects of storage of corneal tissue on corneal cells, Eye, 9, 228-232, 1995.
137. Baer, J. C. and Foster, C. S., Corneal laser photocoagulation for treatment of neovascularization. Efficacy of 577 nm dye laser, Ophthalmology, 99(2), 173-179, 1992.
138. Hemady, R. K., Baer, J. C., and Foster, C. S., Biomicroscopic and histopathologic observations after corneal laser photocoagulation in a rabbit model of corneal neovascularization, Cornea, 12(3), 85-190, 1993.
139. Cohen, R. A., Gebhardt, B. M., and Bazan, N. G., A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization, Curr. Eye Res., 13(2), 139-144, 1994.
140. Racke, M. K., Bonomo, A., and Scott, D. E., Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease, J. Exp. Med., 180, 1961-1966, 1994.
141. Van der Veen, G., Broersma, L., Dijkstra, C. D., et al., Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate, Invest. Ophthalmol Vis. Sci, 35, 3505-3515, 1994.
142. Pleyer, U., Milani, J. K., Dukes, A., et al., Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model, Invest Ophthalmol Vis. Sci., 35, 52-61, 1996.
143. Nussenblatt, R. B. and Palestine, A. G., Uveitis: Fundamentals and Clinical Practice, 2nd ed., MosbyYear Book, St Louis., MO, 1996, 97-134.
144. 136a. Benelli, U., Ross, J. R., Nardi, M., and Klintworth, G. K., Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A, Invest. Ophthalmol. Vis. Sci., 38, 274-282, 1997.
145. BenEzra, D., The role of cyclosporin eye drops in ocular inflammatory diseases, Ocular Immunol. Inflammat., 1(1/2), 159-162, 1993.
146. Chen, Y. F., Gebhardt, B. M., Reidy, J. J., and Kaufman, H. E., Cyclosporine-containing collagen shields suppress corneal allograft rejection, Am. J. Ophthalmol., 109, 132-137, 1990.
147. Mahlberg, K., Uusitalo, R. J., Gebhardt, B., and Kaufman, H. E., Prevention of experimental corneal allograft rejection in rabbits using cyclosporin-collagen shields, Graefe 's Arch. Clin. Exp. Ophthalmol., 229, 69-74, 1991.
148. Pleyer, U., Elkins, B., Ruckert, D., et al. Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields, Curr, Eye Res., 13, 177-181, 1994.
149. Harper, G. A., III, Khoobehi, B., Peyman, G. A., Gerbhardt, B. M., and Dunlap, W. A., Bioavailability of microsphere-entrapped cyclosporine A in the cornea and aqueous of rabbits, Intl. Ophthalmol., 17(6), 337-340, 1993-94.
150. Oh, C., Apel, A. J. G., Seville, B. A., Cheng, Y-L., and Rootman, D. S., Local efficacy of cyclosporine in corneal transplant therapy, Curr. Eye Res., 13, 337-343, 1994.
151. Salisbury, J. D. and Gebhardt, B. M., Suppression of corneal allograft rejection by cyclosporin A, Arch. Ophthalmol., 99, 1640-1643, 1981.
152. Collins, P. W., Misoprostol: discovery, development, and clinical applications, Med, Res. Rev., 10(2), 149-172, 1990.
153. Olsen, T. W., Gothard, T. W., and Holland, E. J., Misoprostol with cyclosporin A prolongs corneal allograft survival in an animal model, Cornea, 15(1), 76-81, 1996.
154. Nishi, M., Herbort, C. P., Matsubara, M., et al., Effects-of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat, Invest. Ophthalmol. Vis. Sci., 34, 2477-2486, 1993.
155. 146a. Hikita, M., Lopez, J. S., Chan, C. C, , Mochizuki, M., Nussenblatt, R. B., and de Smet, M. D., use of topical FK506 in a corneal graft rejection model in Lewis rats, Invest. Ophthalmol Vis. Sci., 38, 901-909, 1997.
156. Rizzo, L. V. and Caspi, R. R., Immunotolerance and prevention of ocular autoimmune disease, Curr. Eye Res., 14, 857-864, 1995.
157. Parks, D. J., Cheung, M. K., Chan, C. C., and Roberge, F. G., The role of nitric oxide in uveitis, Arch. Ophthalmol., 112(4), 544-546, 1994.
158. Larkin, D. F., Oral, H, B., Ring, C. J., Lemoine, N. R., and George, A. J., Adenovirus-mediated gene delivery to corneal endothelium, Transplantation, 61(3), 363-370, 1996.
159. 149a. Fehervari, Z., Rayner, S. A., Oral, H. B., George, A. J. T., and Larkin, D. F. P., Gene transfer to ex vivo stored corneas, Cornea, 16(4), 459-464, 1997.
160. Yao, Y. F., Inoue, Y., Miyazaki, D., Hara, Y., Shimomura, Y., Tano, Y., and Ohashi, Y., Correlation of anterior chamber-associated immune deviation with supression of corneal epithelial rejection in mice, Invest. Ophthalmol. Vis. Sci., 38, 292-300, 1997.
161. Thompson, V., Durrie, D., and Cavanaugh, T. B., Philosophy and technique for excimer laser phototherapeutic keratectomy, Refract. Corneal Surg., 9(2 Suppl), S81-S85, 1993.
162. Arenas-Archila, E., Deep lamellar keratoplasty dissection of host tissue with intrastromal air injection, Cornea, 3, 217-218, 1985.
163. Chau, G. K., Dilly, S. A., Sheard, C. E., and Rostron, C. K., Deep lamellar keratoplasty on air with lyophilised tissue, Br. J. Ophthalmol., 76, 646-650, 1992.
164. Coster, D. J., Aggarwal, R. K., and Williams, K. A., Surgical management of ocular surface disorders using conjunctival and stem cell allografts, Br, J. Ophthalmol., 79, 977-982, 1995.
165. Rufz-Montenegro, J., Swan, J. L., McCuilley, J. P., Terán, L., and Rocha, G., Corneal xenotransplant, Invest. Ophthalmol. Vis. Sci., 32(4), 1237, (abstract), 1991.
166. Larkin, D. F. P. and Williams, K. A., The host response in experimental corneal xenotransplantation, Eye, 9, 254-260, 1995.
167. Ross, J. R., Howell, D. N., and Sanfllippo, F. P., Characteristics of corneal xenograft rejection in a discordant species combination, Invest. Ophthalmol. Vis, Sci., 34(8), 2469-2476, 1993.